Meta-analysis as a method of evaluating adjuvant therapy for gastrointestinal cancer

Annals of Cancer Research and Therapy

Volumn 5, Issue 1, 1996, Pages 5-12

  Sakamoto, Junichi ^a   Kojima, Hiroshi ^a   Yasue, Mitsunori ^a  

^a AICHI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8744263562     PISSN: 13446835     EISSN: None     Source Type: Journal    
DOI: 10.4993/acrt1992.5.5     Document Type: Article

References (50)

1. Health and welfare Statistics Association. Number of deaths caused by specific types of cancers. J Health and Welfare Statistics, 41: 51, 1994.
2. Early Breast Cancer Trialists’ Collaborative Group. Effects of adjuvant tamoxifen and cytotoxic therapy on mortality in early breast cancer. N Engl J Med. 319: 1681–1692, 1988.
3. Stewart LA, Parmar MKB. Meta-analysis of the literature or individual patient data: is there a difference? Lancet, 341: 418–422, 1993
4. Pignon JP, Arriagada R. Meta-analysis. Lancet, 341: 418–422. 1993.
5. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs. individual patient data. JAMA, 274: 830–846, 1995.
6. Stewart LA, Clarke MJ. Practical methodology of meta-analysis (overviews) using updated individual patient data. Stat Med. 14: 2057–2079, 1955.
7. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. JAMA, 267: 374–378, 1992.
8. Cook DJ, Guyatt GH, Ryan. Should unpublished data be included in the meta-analysis. JAMA, 269: 2749–2753, 1993.
9. Sakamoto J, Hirai T, Ito K, Nakazato H, Kito T. Meta-analysis of clinical trials on the treatment of colorectal cancer: report of the first colorectal cancer collaboration meeting in Oxford. Jpn J Cancer Chemother, 21: 123–128, 1994, (in Japanese).
10. Early Breast Cancer Trialists’ Collaborative Group. Treatment of early breast cancer Vol 1. Worldwide evidence. 1985–1990. Oxford University Press, Oxford, 1990.
11. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet, 339: 1–15, 71–85, 1992.
12. Sakamoto J, Nakakawaji K, Uchida T, Yasue M, Nakazato H. Fourth Early Breast Cancer Trialists’ Collaborative Group meeting in Oxford: meta-analysis of early breast cancer clinical trials. Jpn J Cancer Chemother, 23: 373–378, 1996, (in Japanese).
13. Advanced Ovarian Cancer Trialist Group. Chemotherapy in advanced ovarian cancer: an overview of randomized clinical trials. Br Med J, 303: 884–893, 1991.
14. Ovarian Cancer Meta-analysis Project. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin and cisplatin chemotherapy of ovarian cancer: a meta-analysis. J Clin Oncol, 9: 1668–1674, 1991.
15. Advanced Colorectal Cancer Meta-analysis Project. Modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol, 10: 896–903, 1992.
16. Advanced Colorectal Cancer Meta-analysis Project. Meta-analysis of randomized trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colon cancer. J Clin Oncol, 12: 960–969, 1994.
17. Wolmark N, Fisher B, Rockette H. Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst, 80: 30–36, 1988.
18. Fisher B, Wolmark N, Roctulle H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer. Results from NSABP Protocol R-01. J Natl Cancer Inst, 80: 21–29, 1988.
19. National Institute of Health. Consensus Development Conference: Adjuvant therapy for patients with colon and rectum cancer. 1990.
20. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer: why we still don’t know. J Am Med Assoc, 259: 3571–3578, 1988.
21. Mayer RJ. Does adjuvant therapy work in colon cancer? N Engl J Med, 322: 399–401, 1990.
22. Kato T. Chemotherapy of colorectal cancer with long term follow-up. Chemotherapy, 36: 969–970, 1988.(in Japanese)
23. Hojo K, Kajitani T. Adjuvant chemotherapy of colorectal cancer: results of prospectively randomized trials. Jpn J Cancer Chemother, 13: 3063–3073, 1986, (in Japanese).
24. Nakazato H, Ichihashi H, Kondo T. Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinone and Krestin for patients with curatively resected gastric cancer. Jpn J Cancer Chemother, 13: 308–318, 1986, (in Japanese).
25. Matsuda T, Yasutomi M, Kikuchi K, Kasai Y, Abe O, Kondo T, Taguchi T, Hattori T, Inokuchi K, Komi N, Ogawa N. Cooperative study of surgical adjuvant chemotherapy for colorectal cancer: Five year results. Jpn J Cancer Chemother, 18: 461–469, 1991, (in Japanese).
26. The Colorectal Cancer Chemotherapy Study Group of Japan. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol, 25: 91–103, 1995.
27. Ito K, Yamaguchi A, Miura K, Kato T, Baba S, Matsumoto S, Ishii M, Takagi H. Prospective randomized trial of oral adjuvant therapy with 5-FU derivative Carmofur (HCFU) for colorectal cancer: 5 years follow up. Proceedings of the 32nd Annual Meeting of ASCO, 15, 1996.
28. Sakamoto J, Hamada C, Kodaira S, Origasa H, Ohashi Y, Nakazato H. Meta-analysis as a method of evaluation for adjuvant chemotherapy of colorectal cancer. Proceedings of the 5th Congress of the Asian Federation of Coloproctology, 9, 1995.
29. Moertel C, Fleming T, McDonald J. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med, 322: 352–358, 1990.
30. Chlebowski RT, Lillington L, Nystrom JS. Late mortality and levamisole adjuvant therapy in colorectal cancer. Br J Cancer, 69: 1094–1097, 1994.
31. Sakamoto J, Yasue M. Extensive lymphadenectomy for gastric cancer patients: what can the results of one trial tells us. Lancet, 345: 742–743, 1995.
32. Imanaga H, Nakazato H. Results of surgery for gastric cancer and effect of adjuvant mitomycin-C on cancer recurrence. World J Surg, 60: 733–41, 1979.
33. Inokuchi K, Hattori T, Taguchi T. Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years. Cancer, 53: 2393–2397, 1984.
34. Sakamoto J, Nakazato H, Yasue M. Change of the protocols of ajuvant therapy for clinical trials against gastrointestinal cancers. Proceedings of the 33rd Annual Meeting of the Japan Society for Cancer Therapy, 30, 1995.
35. Sasako M, Maruyama K. Adjuvant chemotherapy of gastric cancer has to be fundamentally reconsidered. Igaku-no-ayumi, 153: 664–668, 1990, (in Japanese).
36. Sasako M, Sano T, Katai H, Okajima K, Maruyama K. Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer. Jpn J Cancer Chemother, Suppl III. 21: 384–394, 1994, (in Japanese).
37. Kimura T, Koyama Y. Three prospective controlled studies-part 2. Rinshougeka, 36: 185–195, 1981.(in Japanese)
38. Imanaga H, Nakazato H. Three prospective controlled studies-part 1. Rinshougeka, 36: 175–183, 1981.(in Japanese)
39. Nakajima T, Kajitani T. Adjuvant chemotherapy with multiagent induction and long-term oral maintenance therapy for gastric cancer. J Jap Soc Cancer Ther, 15: 980–988, 1980, (in Japanese).
40. Nakajima T, Takahashi T, Takagi K, Kuno K, Kajitani T. Comparison of 5-fluorouracil with Frorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol, 2: 1366–1370, 1984.
41. Yamamura Y, Nishimura M, Sakamoto J, Yasui K, Morimoto T, Kato T, Yasue M, Kito T, Miyaishi S, Nakazato H. A randomized controlled trial of adjuvant therapy with mitomycin C, 5-fluorouracil, and OK-432 for patients with gastric cancer. Jpn J Cancer Chemother, 13: 2134–2140, 1986, (in Japanese).
42. Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Ohyama S, Sasako M, Van de Velde CJH. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol, 11: 1441–1447, 1993.
43. Pignon JP, Ducreux M, Rougier P. Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal. J Clin Oncol, 12: 877–879, 1994.
44. Hermans J, Bonenkamp H. Meta-analyses need time, collaboration, and funding. Authors’ reply. J Clin Oncol, 12: 879–880, 1994.
45. Kondo T, Sakamoto J, Nakazato H. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection. Biotherapy, 3: 287–295, 1991.
46. Kondo T, Ichihashi H, Nakazato H. Effect of adjuvant immunochemotherapy using Krestin and Ftraful on 8 year survival in gastric cancer patients after radical gastrectomy: a randomized controlled trial by a cooperative study group. Biotherapy, 3: 655–664, 1989, (in Japanese).
47. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet, 343: 1122–1126, 1994.
48. Horwitz R. “Large scale randomized evidence: Large simple trials and overviews of trials” discussion. A clinician's perspective on meta-analysis. J Clin Epidemiol, 48: 41–44, 1995.
49. Olkin I. Meta-analysis: reconciling the results of independent studies. Stat Med, 14: 457–472, 1995.
50. Peto R, Collins R, Gray R. Large scale randomized evidence: large simple trials and overviews of trials. J Clin Epidemiol, 48: 23–40, 1995.